6951 - 7000 of 8785 Results
Title
Year
-
OPENTitle: The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 5Start Page: 1557End Page: 1565Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14733Best OA location URL: https://doi.org/10.1111/ene.14733Citation Count: 23
-
OPENTitle: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s DiseaseJournal Name: Archives of Clinical NeuropsychologyPublisher: Oxford University Press (OUP)Vol: 36Issue #: 1Start Page: 112End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/arclin/acz067Best OA location URL: https://academic.oup.com/acn/article-pdf/36/1/112/35858436/acz067.pdfCitation Count: 5
-
OPENTitle: A highly efficient, scalable pipeline for fixed feature extraction from large-scale high-content imaging screensJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 12Start Page: 111434End Page: 111434Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.isci.2024.111434Best OA location URL: https://doi.org/10.1016/j.isci.2024.111434Citation Count: 0
-
OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 1
-
RESTRICTEDTitle: A cognitive fMRI study in non-manifesting LRRK2 and GBA carriersJournal Name: Brain Structure and FunctionPublisher: Springer Science and Business Media LLCVol: 222Issue #: 3Start Page: 1207End Page: 1218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00429-016-1271-4Citation Count: 21
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 9
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 7
- Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disorders2024OPENTitle: Elevated cholesterol is a common phenotype for dominant and recessive ATAD3-associated disordersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awae402Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awae402/61091141/awae402.pdfCitation Count: 1
-
RESTRICTEDTitle: At last, a randomised controlled trial of apomorphine infusionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 9Start Page: 732End Page: 733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30284-9Citation Count: 3
-
OPENTitle: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’sJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12789-0Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-024-12789-0.pdfCitation Count: 5
-
OPENTitle: Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-023-00346-0Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-023-00346-0Citation Count: 26
-
OPENTitle: First-in-Human PET Imaging of [18F]SDM-4MP3: A Cautionary TaleJournal Name: Molecular ImagingPublisher: SAGE PublicationsVol: 2023Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2023/8826977Best OA location URL: https://downloads.hindawi.com/journals/moi/2023/8826977.pdfCitation Count: 2
-
OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
-
OPENTitle: Multimodal assessment of nigrosomal degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 102End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021Best OA location URL: https://arxiv.org/pdf/2009.01378Citation Count: 17
-
OPENTitle: Paroxysmal abdominalgia as a non-motor wearing off phenomenon in Parkinson’s disease. A case series and literature reviewJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 13Issue #:Start Page: 100368End Page: 100368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100368Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100368Citation Count: 0
-
RESTRICTEDTitle: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 100Issue #:Start Page: 109871End Page: 109871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871Citation Count: 29
-
OPENTitle: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification AssayJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1173End Page: 1177Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26917Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26917Citation Count: 18
-
RESTRICTEDTitle: Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurementJournal Name: Clinical Chemistry and Laboratory Medicine (CCLM)Publisher: Walter de Gruyter GmbHVol: 59Issue #: 10Start Page: 1653End Page: 1661Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/cclm-2020-1521Citation Count: 6
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
- Falls in people with Parkinson’s disease: A prospective comparison of community and home-based falls2017RESTRICTEDTitle: Falls in people with Parkinson’s disease: A prospective comparison of community and home-based fallsJournal Name: Gait & PosturePublisher: Elsevier BVVol: 55Issue #:Start Page: 62End Page: 67Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.gaitpost.2017.04.005Citation Count: 41
-
RESTRICTEDTitle: Exploring the neuroprotective potential of immunosuppressants in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107294End Page: 107294Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107294Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.107294Citation Count: 0
-
OPENTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 50
-
OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
-
OPENTitle: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's DiseaseJournal Name: Advanced MaterialsPublisher: WileyVol: 35Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adma.202304654Best OA location URL: https://doi.org/10.1002/adma.202304654Citation Count: 58
-
RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 8Start Page: 1878End Page: 1878Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9081878Best OA location URL: https://www.mdpi.com/2073-4409/9/8/1878/pdf?version=1597644425Citation Count: 6
-
OPENTitle: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104497End Page: 104497Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497Best OA location URL: https://repositorio.uchile.cl/handle/2250/172258Citation Count: 18
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 1
-
OPENTitle: Differential serum microRNAs in premotor LRRK2 G2019S carriers from Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00451-xBest OA location URL: https://www.nature.com/articles/s41531-023-00451-x.pdfCitation Count: 10
-
RESTRICTEDTitle: Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 592End Page: 602Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000167Citation Count: 24
-
OPENTitle: Understanding the Neurobiology of Cd200 and the Cd200 Receptor: A Therapeutic Target For Controlling Inflammation In Human Brains?Journal Name: Future NeurologyPublisher: Informa UK LimitedVol: 8Issue #: 3Start Page: 321End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2217/fnl.13.14Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3815586Citation Count: 50
-
OPENTitle: Enhanced Parkinson’s Disease Tremor Severity Classification by Combining Signal Processing with Resampling TechniquesJournal Name: SN Computer SciencePublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s42979-021-00953-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s42979-021-00953-6.pdfCitation Count: 18
-
OPENTitle: Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein FibrilsJournal Name: NeurosciencePublisher: Elsevier BVVol: 437Issue #:Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.04.032Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7510511Citation Count: 19
-
OPENTitle: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X MouseJournal Name: BiomedicinesPublisher: MDPI AGVol: 9Issue #: 5Start Page: 514End Page: 514Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines9050514Best OA location URL: https://www.mdpi.com/2227-9059/9/5/514/pdf?version=1620466923Citation Count: 6
-
RESTRICTEDTitle: Clinician-Input Study (CIS-PD): how the Fox Wearable Companion Application can influence treatment and care in Parkinson’s disease (P3.048)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p3.048Citation Count: 4
-
OPENTitle: TMEM106B haplotypes have distinct gene expression patterns in aged brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0268-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0268-2Citation Count: 37
- Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants2024RESTRICTEDTitle: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107041End Page: 107041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041Citation Count: 0
-
OPENTitle: The intracellular milieu of Parkinson’s disease patient brain cells modulates alpha-synuclein protein aggregationJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01256-wBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01256-wCitation Count: 11
- Resonance assignments of an α-synuclein fibril prepared in Tris buffer at moderate ionic strength2018OPENTitle: Resonance assignments of an α-synuclein fibril prepared in Tris buffer at moderate ionic strengthJournal Name: Biomolecular NMR AssignmentsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 195End Page: 199Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12104-018-9808-5Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5877819Citation Count: 16
-
OPENTitle: PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific mannerJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-07124-4Best OA location URL: https://doi.org/10.1038/s41419-024-07124-4Citation Count: 2
-
OPENTitle: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Best OA location URL: https://doi.org/10.1016/j.isci.2024.110956Citation Count: 1
- A dual-functional substrate for quantitation of substrate levels and GCase activity in living cells2025OPENTitle: A dual-functional substrate for quantitation of substrate levels and GCase activity in living cellsJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 6Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d5cb00045aBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2025/cb/d5cb00045aCitation Count: 0
-
OPENTitle: Cocaine and desipramine elicit distinct striatal noradrenergic and behavioral responses in selectively bred obesity-resistant and obesity-prone ratsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 346Issue #:Start Page: 137End Page: 143Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5860948Citation Count: 3
-
OPENTitle: Humanized Biomimetic Nanovesicles for Neuron TargetingJournal Name: Advanced SciencePublisher: WileyVol: 8Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/advs.202101437Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/advs.202101437Citation Count: 26
-
OPENTitle: NeuroBridge: a prototype platform for discovery of the long-tail neuroimaging dataJournal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fninf.2023.1215261Best OA location URL: https://www.frontiersin.org/articles/10.3389/fninf.2023.1215261/pdfCitation Count: 6
-
OPENTitle: Alzheimer's disease: Pathogenesis and preventionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 3Start Page: 227End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2012.01.011Citation Count: 97
-
OPENTitle: Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particlesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 8Start Page: e0181844End Page: e0181844Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0181844Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0181844&type=printableCitation Count: 31
-
OPENTitle: Selective Fluorogenic β-Glucocerebrosidase Substrates for Convenient Analysis of Enzyme Activity in Cell and Tissue HomogenatesJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 4Start Page: 824End Page: 829Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.9b01044Citation Count: 10
-
OPENTitle: LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterizationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcaf103Best OA location URL: https://doi.org/10.1093/braincomms/fcaf103Citation Count: 0
-
OPENTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Citation Count: 45